On the other hand, ERK5 deficiency on its own accelerated the rate of tumor growth in spite of evidence that long-term ERK5 silencing did not give MDA-MB-453 cells a proliferative advantage in vitro (Fig. 7A; Supplementary Fig. S10B). The gene discussed is MAPK7; the disease is neoplasm.